Tellgen
Shanghai Tellgen Life Sciences Co., Ltd. (Tellgen Corporation) is a Chinese in vitro diagnostics (IVD) company founded in 2003 and headquartered in Shanghai, focused on the research, development, manufacture, and distribution of high-end diagnostic reagents and instruments. Its portfolio spans tumor markers, HPV detection, autoimmune antibodies, infectious disease, thrombosis and reproductive-health assays across flow-fluorescence, chemiluminescence, real-time PCR / molecular, and clinical-chemistry platforms (TESMI analyzer family). The company was listed on the Shenzhen Stock Exchange ChiNext board in April 2017 (ticker 300642) and counts Qiming Venture Partners among its early investors. Tellgen is a medical-device and laboratory-reagent manufacturer and publishes no public developer API, SDK, or developer portal.
Tellgen is profiled on the APIs.io network. Tagged areas include Company, In Vitro Diagnostics, IVD, Medical Devices, and Diagnostics.
Kin Score
Resources
Company 1
The organization behind the API